About
Basic Data Updated:
30 days agoThemis Medicare Limited is a company that is involved in the production of pharmaceuticals and medicinal chemicals, specifically formulations and Active Pharmaceutical Ingredients (APIs). The APIs that are manufactured by the company consist of various products such as Simvastatin, which is known for its ability to lower cholesterol levels, Ethambutol, an anti-tuberculosis medication, and anti-malarial products like Artemether, Artesunate, and Arteether. Additionally, the company also produces Di Methyl Isosorbide, an additive, and other similar products. TML's range of formulations includes original products, new drug delivery systems (NDDS), and dietary supplements, among others. The company's headquarters are located in Mumbai, and it operates four manufacturing facilities in Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal).
Industry
Company Details
- Location
Valsad, Gujarat, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
Products or Services related to Themis Medicare Limited
Financials of Themis Medicare Limited
Themis Medicare Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.81% decrease. The company also saw a substantial fall in profitability, with a 29.67% decrease in profit. The company's net worth Soared by an impressive increase of 15.75%.
Corporate Structure
Unlock access to Themis Medicare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in Themis Medicare Limited
Unlock and access historical data on people associated with Themis Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (3)
SD
Sachin Dinesh Managing DirectorAppointment Date: 29-Jun-2007
Status: Current
SI
S Iyer Company SecretaryAppointment Date: 21-Aug-2017
Status: Current
TD
Tushar Dalal CFOAppointment Date: 01-Oct-2016
Status: Current
Board Members(8)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 06 Feb 2024 | ₹3.60 M | Open |
Others Creation Date: 05 Feb 2024 | ₹1.30 M | Open |
Others Creation Date: 05 Feb 2024 | ₹1.80 M | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of Themis Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Themis Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Rcube Energy Storage Systems Private Limited
Active 4 years 10 monthsShishir Dalal is a mutual person
Long Island Nutritionals Private Limited
Active 29 years 1 monthSachin Dinesh and Rajneesh Anand are mutual person
Eurus First Financial Partners Private Limited
Active 2 years 4 monthsShishir Dalal is a mutual person
Recent activity within the organization
Charges
A charge with Others amounted to Rs. 0.36 cr with Charge ID 100858301 was registered on 06 Feb 2024.
06 Feb 2024Charges
A charge with Others amounted to Rs. 0.13 cr with Charge ID 100858289 was registered on 05 Feb 2024.
05 Feb 2024Charges
A charge with Others amounted to Rs. 0.18 cr with Charge ID 100858293 was registered on 05 Feb 2024.
05 Feb 2024Charges
A charge with Others amounted to Rs. 0.08 cr with Charge ID 100858332 was registered on 05 Feb 2024.
05 Feb 2024Charges
A charge with Others amounted to Rs. 0.08 cr with Charge ID 100858367 was registered on 05 Feb 2024.
05 Feb 2024
Recent News, Updates & Announcement
- Themis Medicare introduces novel opioid analgesic REMITHEM in India.
Business News Today 10 Nov 2023
- Themis Medicare inks pact with Nevakar for injectable products.
The New Jerseybased specialty pharmaceutical firm Navakar has expertise in commercialising pharma products in the US as well as global markets.
Economic Times 10 Mar 2023
- Themis Medicare Standalone December 2022 Net Sales at Rs 8878 crore down 647 YoY.
Moneycontrol 04 Feb 2023
- Themis launches terms of IPO.
European Biotechnology 29 Oct 2018
- EMA grants PRIME designation to Themis chikungunya vaccine candidate.
News Medical 11 Jun 2018
Frequently asked questions
What is the Incorporation or founding date of Themis Medicare Limited?